1-3 of 3
Janice Staber
Close
Sort by
Journal Articles

Real-World Data of Immune Tolerance Induction Using rFVIIIFc in Subjects With Severe Hemophilia A With Inhibitors at High Risk for ITI Failure

Manuel Carcao, Amy Shapiro, Nina Hwang, Steven Pipe, Sanjay Ahuja, Kenneth Lieuw, MD PhD, Janice Staber, Haowei Linda Sun, Hilda Ding, Michael Wang, Macgregor Steele, Elisa Tsao, Jing Feng, Zahra Al-Khateeb, Jennifer Dumont, Nisha Jain
Journal: Blood
Blood (2018) 132 (Supplement 1): 2500.
https://doi.org/10.1182/blood-2018-99-110467
Published: 2018
Journal Articles

Data Coming out of the Human Inhibitor PUP Study (HIPS) Reveal 4 Subgroups of Patients with Distinct Antibody Signatures

Bagirath Gangadharan, PhD, Birgit M Reipert, Verena Berg, MS, Friedrich Scheiflinger, PhD, Jan Blatny, MDPhD, K Fijnvandraat, MD PhD, Ralph A. Gruppo, MD, Jenny Klintman, MD PhD, Christoph Male, MD, Catherine E. McGuinn, MD, Shannon L. Meeks, MD, Vlad Calin Radulescu, MD, Margaret V. Ragni, MD MPH, Michael Recht, MD PhD, Elena Santagostino, MD PhD, Amy Shapiro, Janice Staber, Hassan M. Yaish, MD, Donald L Yee, MD, Deborah Brown, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3774.
https://doi.org/10.1182/blood-2018-99-115979
Published: 2018
Journal Articles

BIVV001: The First Investigational Factor VIII Therapy to Break Through the VWF Ceiling in Hemophilia A, with Potential for Extended Protection for One Week or Longer

Barbara A Konkle, Amy Shapiro, Doris Quon, Janice Staber, Takashi Suzuki, MD PhD, Stacey Poloskey, Kara Rice, Suresh Katragadda, Dan Rudin, Joachim Fruebis
Journal: Blood
Blood (2018) 132 (Supplement 1): 636.
https://doi.org/10.1182/blood-2018-99-113575
Published: 2018